AEON Biopharma (AEON) News Today → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free AEON Stock Alerts $1.53 +0.03 (+2.00%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 2:04 AM | americanbankingnews.comAEON Biopharma, Inc. Expected to Post Q2 2024 Earnings of ($0.19) Per Share (NASDAQ:AEON)May 19 at 4:02 AM | americanbankingnews.comHC Wainwright Weighs in on AEON Biopharma, Inc.'s FY2028 Earnings (NASDAQ:AEON)May 17 at 10:44 AM | marketbeat.comAEON Biopharma, Inc. (NASDAQ:AEON) Expected to Earn FY2028 Earnings of $0.18 Per ShareAEON Biopharma, Inc. (NASDAQ:AEON - Free Report) - Investment analysts at HC Wainwright issued their FY2028 EPS estimates for AEON Biopharma in a report issued on Wednesday, May 15th. HC Wainwright analyst D. Tsao anticipates that the company will earn $0.18 per share for the year. HC WainwrightMay 17 at 2:42 AM | americanbankingnews.comAEON Biopharma (NASDAQ:AEON) PT Lowered to $6.00May 15, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Price Target Cut to $6.00HC Wainwright dropped their target price on AEON Biopharma from $18.00 to $6.00 and set a "buy" rating on the stock in a research report on Wednesday.May 15, 2024 | finance.yahoo.comAEON Biopharma, Inc. (AEON)May 14, 2024 | globenewswire.comAEON Biopharma Reports First Quarter 2024 Financial ResultsMay 9, 2024 | globenewswire.comAEON Biopharma Provides Update on Development PipelineMay 7, 2024 | markets.businessinsider.comMaintaining Buy on AEON Biopharma: Potential of ABP-450 Despite Phase 2 SetbackMay 6, 2024 | marketbeat.comAEON Biopharma's (AEON) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $18.00 price target on shares of AEON Biopharma in a report on Monday.May 3, 2024 | msn.comNewly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here WhyMay 3, 2024 | finance.yahoo.comUS Equity Markets Close Higher Friday Following Weak Jobs ReportMay 3, 2024 | markets.businessinsider.comAEON Says Preliminary Results From Phase 2 Interim Analysis Of ABP-450 Fails To Meet Primary GoalMay 3, 2024 | globenewswire.comAEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic MigraineApril 19, 2024 | marketbeat.comHC Wainwright Analysts Boost Earnings Estimates for AEON Biopharma, Inc. (NASDAQ:AEON)AEON Biopharma, Inc. (NASDAQ:AEON - Free Report) - Stock analysts at HC Wainwright upped their Q1 2024 earnings per share (EPS) estimates for AEON Biopharma in a report issued on Wednesday, April 17th. HC Wainwright analyst D. Tsao now expects that the company will earn ($0.31) per share for theApril 18, 2024 | markets.businessinsider.comAEON Biopharma: Buoyant Prospects Following FDA Alignment on Migraine StudiesApril 18, 2024 | marketbeat.comAEON Biopharma, Inc. Forecasted to Earn Q1 2025 Earnings of ($0.29) Per Share (NASDAQ:AEON)AEON Biopharma, Inc. (NASDAQ:AEON - Free Report) - Equities researchers at HC Wainwright issued their Q1 2025 earnings estimates for AEON Biopharma in a report released on Wednesday, April 17th. HC Wainwright analyst D. Tsao expects that the company will post earnings per share of ($0.29) for theApril 17, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $18.00 price objective on shares of AEON Biopharma in a research report on Wednesday.March 30, 2024 | globenewswire.comCORRECTION -- AEON Biopharma Announces Redemption of Public WarrantsMarch 29, 2024 | globenewswire.comAEON Biopharma Announces Redemption of Public WarrantsMarch 29, 2024 | globenewswire.comAEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | seekingalpha.comLenz stock rallies 22% amid bullish note by Piper SandlerMarch 21, 2024 | investing.comAEON Biopharma secures $15 million in private placementMarch 20, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Shares Gap Down to $14.40AEON Biopharma (NASDAQ:AEON) Shares Gap Down to $14.40March 19, 2024 | globenewswire.comAEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of MigraineMarch 19, 2024 | globenewswire.comAEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase AgreementsMarch 19, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Shares Down 7.2% AEON Biopharma (NASDAQ:AEON) Shares Down 7.2%March 18, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Reaches New 12-Month High at $15.98AEON Biopharma (NASDAQ:AEON) Sets New 52-Week High at $15.98March 15, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Sees Strong Trading VolumeAEON Biopharma (NASDAQ:AEON) Sees Unusually-High Trading VolumeFebruary 26, 2024 | edition.cnn.comAEON Biopharma, Inc. Class AFebruary 6, 2024 | finanznachrichten.deDaewoong Pharmaceutical Co., Ltd.: Daewoong Pharmaceutical Announces 2023 Financial ResultsFebruary 1, 2024 | morningstar.comAeon Kyushu Co Ltd 2653January 31, 2024 | seekingalpha.comAEON.WS AEON Biopharma, Inc. WT EXP 072128January 18, 2024 | finance.yahoo.comAEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin ConferenceJanuary 10, 2024 | investing.comAeon Fantasy Co Ltd (4343)December 20, 2023 | morningstar.comXeris Biopharma Holdings Inc XERSDecember 12, 2023 | finance.yahoo.comAEON Biopharma Completes Enrollment in Phase 2 Study of ABP-450 (prabotulinumtoxinA) for Preventive Treatment of Chronic MigraineNovember 15, 2023 | finance.yahoo.comAEON Biopharma Inc Reports Q3 2023 Financial Results Amid Clinical AdvancementsNovember 14, 2023 | msn.comAEON Biopharma, Inc. GAAP EPS of -$0.04November 13, 2023 | finance.yahoo.comAEON Biopharma Reports Third Quarter 2023 Financial Results Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market. Click for his six specific AI stock in the crosshairs AEON Media Mentions By Week AEON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEON News Sentiment▼0.710.42▲Average Medical News Sentiment AEON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEON Articles This Week▼131▲AEON Articles Average Week Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EGRX News CARM News KRON News MURA News CALC News ANEB News IMMX News ELDN News TLSA News KZR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEON) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
